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ABSTRACT
The roles of antigen-specific immune reactions are
discussed in different types of autoimmune diseases.
Antigen-specific reactions of T cells are carried out at 
the level of clones. In this regard, we have established a
novel method for analyzing T cell clonality. Analyses of
several autoimmune disorders suggest the importance
of antigen-specific T cell clones. Furthermore, our find-
ings cast doubt on the idea of epitope spreading, which
has been proposed recently for T cell activation in auto-
immune processes. Our system also appears to work as
a new method for the identification of target antigens
recognized by such accumulated T cell clones.
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ANTIGEN-SPECIFIC IMMUNE REACTIONS IN
DIFFERENT TYPES OF AUTOIMMUNE DISEASES
There is a spectrum of autoimmune diseases. At one end
of this spectrum are organ-specific autoimmune diseases,
such as Hashimoto’s disease, which is characterized by
autoantibodies specific to thyroid antigens as well as
mononuclear cell infiltrations of the thyroid gland. At the
other end of the spectrum are systemic autoimmune 
diseases. Systemic lupus erythematosus (SLE) is a repre-
sentative example and the lesions and autoantibodies 
are not confined to any one organ. Between these two
extremes, there are intermediate conditions in which
autoantibodies are organ non-specific but the lesion is
localized to a certain organ.
In organ-specific autoimmune diseases, antigens in the
target organ appear to drive the autommune response.1
Animal experiments, such as immunizing animals with an
organ-specific antigen with a strong adjuvant, clearly
show that a specific immune response to the self-antigen
can elicit autoimmune diseases. Evidence that the suscep-
tibility to certain autoimmune diseases is controlled by the
major histocompatibility complex (MHC) also suggests
that T cells are deeply involved in this process.2
In contrast, in systemic autoimmune diseases, several
antigen-non-specific functional disturbances have been
reported in various immune cells. They are, for example,
activation of polyclonal B cells, abnormal distribution of 
T cell subsets, altered cytokine production, aberrant
signals for apoptosis and functional alterations of mono-
cytes and macrophages. In contrast, there is a lack of
knowledge about antigen-specific immune responses.
Therefore, several investigators believe that antigen-
specific immune responses do not play important roles in
systemic types of autoimmune disease.3
T CELLS IN ANTIGEN-SPECIFIC AUTOIMMUNE
DISEASES
T cells recognize an antigen by means of T cell receptors
(TCR). Most T cells express TCR consisting of α- and 
β-subunits, while others express γ- and δ-subunits. In
each T cell, the TCR gene has acquired vast variability by
means of gene rearrangement and random deletion and
insertion of nucleotide sequences on the borders of the V,
D and J regions. When a population of T cells with this
infinite variability of TCR reacts to an antigen, the reac-
tion activates T cells that have TCR recognizing the
complex of the MHC molecule and the antigen peptide.
This is because the reacting TCR transmit growth signals
in the cells and these cells proliferate and grow. The
population of T cells having the same rearranged TCR
are referred to as a clone. Therefore, antigen-specific
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reactions of T cells are carried out at the level of clones.
Thus, it is important to evaluate whether T cells are clon-
ally accumulated in a lymphocyte population to determine
the existence of antigen-specific T cell responses.
In contrast, it is important to notice that TCR display a
high degree of cross-reactivity in their recognition.
Therefore, cross-reactivity between autoreactive T cells
and microbial antigens may facilitate the development
of autoimmune diseases.4 For example, a recent study of
Lyme disease suggests that this is an autoimmune
process against the lymphocyte function-associated
antigen (LFA)-1 protein expressed on activated T cells
triggered by cross-reactive activation by Borrelia burg-
dorferi outer surface protein A.5
ESTABLISHMENT OF A T CELL CLONALITY
ANALYSIS SYSTEM
We have established a novel method for analyzing T cell
clonality using reverse transcription–polymerase chain
reaction (RT-PCR) of TCR messages containing the most
variable area, called the CDR3 region, and subsequent
electrophoretic separation of the PCR product based on
their single-strand conformation polymorphism (SSCP)6
(Fig. 1). Using this method, an analysis of peripheral
blood lymphocytes (PBL) obtained from a healthy individ-
ual revealed that each of the PCR products representing
each of BV1 to BV20 exhibited a smear-like pattern. This
pattern reflects the heterogeneity of the CDR3 region of
the TCR β messages. We then stimulated the hetero-
geneous PBL with a mitogen, such as concanavalin A
(Con A) or phytohemagglutinin (PHA). Such stimulation
did not change the smear-like pattern. In contrast, when
PBL were cultured in the presence of the tuberculin
antigen purified protein derivative (PPD), several distinct
bands appeared in the background smear pattern, indi-
cating that the clones corresponding to these bands had
been activated and had proliferated in the culture. A
time-course analysis revealed that the number of these
bands increased progressively during stimulation. CD4+
clones were detected at first and CD8 clones then
appeared to accumulate. We also followed the changes
in the clonality of PBL in vivo before and after a flu-like
infection. Accumulation of distinct T cell clones was again
observed. Considering these findings, it is obvious that
this method allows us to monitor the dynamic changes 
in accumulating T cell clones during antigen-specific
immune reactions.
T CELL CLONAL ANALYSES OF AUTOIMMUNE
DISEASES
Rheumatoid arthritis (RA) is believed to be mediated by
autoimmune reactions, but it remains controversial as to
whether T cells are really involved in the pathogenesis of
RA. We analyzed T cell clonality in synovial samples
obtained from RA patients during therapeutic syno-
vectomy. Analysis showed that even though there were
distinct clonal accumulations of T cell clones in the PBL 
of RA patients compared with healthy individuals, the 
synovial tissue samples contained even more distinct
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Fig. 1 Schematic diagram of the T cell clonality analysis.
TCR, T cell receptor; PCR, polymerase chain reaction; SSCP,
single-strand conformation polymorphism.
accumulations of T cell clones. This indicates that there
are antigen-specific T cell reactions in RA lesions. We
then compared the T cell clonality among different joint
lesions. With the SSCP system, identical clones generate
bands that migrate to the same position in the gel. Thus,
the identity of the clones could be compared when the
PCR products from different samples were analyzed in
adjacent lanes of the same gel. We found 70–90% of the
accumulating T cell clones identified in one joint lesion
also existed in other joints. This suggests that the same
pathogenic immune reactions occur in multiple joints. In
addition, the samples that were analyzed in our study 
represented rather advanced stages of RA. This suggests
that pathologic lesions in advanced stages of RA are
mediated by antigen-specific T cells.7
In addition, PBL from SLE were analyzed. Systemic
lupus erythematosus patients in remission showed only a
slight clonotypic expansion of T cell clones. However, PBL
from patients with active SLE possessed a number of
dominant clonal accumulations. Following administra-
tion of a high dose of steroids, these patients became
inactive and the accumulated T cell clones in the PBL 
disappeared. Therefore, the degree of T cell clonal accu-
mulation appears to correlate with the degree of disease
activity.
Analysis of an organ-specific autoimmune disease also
revaled similar results. For example, in patients with
Graves’ disease, accumulation of identical T cell clones
in the right and left lobes of the thyroid gland was demon-
strated, suggesting that there are immune responses
driven by factors common to both lobes, such as thyroid-
specific antigens.
During these analyses, we have found that T cell clones
accumulated in lesions obtained from advanced phases
of a disease were not necessarily large in number com-
pared with those found in the relatively early phases. This
finding does not fit with the idea of ‘epitope spreading’
recently proposed for T cell activation behavior in the
autoimmune process.8 According to this ‘epitope spread-
ing’, the autoimmune epitopes may be limited in the
initiation phase of the disease, but those recognized by 
T cells should spread during disease development and
multiple T cell clones recognizing multiple autoepitopes
should be activated in the relatively late phase of the
disease. In order to know the real changes in activated 
T cell clones during the autoimmune process, we are now
examining several models of spontaneous autoimmune
mice. Our results so far do not support the ‘epitope
spreading’ concept and, instead, suggest that T cell
clones accumulated in the late phase of the disease are
rather restricted and appear to play important roles in the
pathogenesis. Thus, these T cells should be the target of
therapy in the future.
IDENTIFICATION OF TARGET ANTIGENS
RECOGNIZED BY ACCUMULATED T CELL CLONES
To date, there are only a few methods available to identify
the target antigens recognized by accumulated T cell
clones. These include establishing T cell lines, stimulation
with putative antigens and measurement of cell pro-
liferation as a total lymphocyte population and the
antigen–MHC tetramer technique. However, none of
these methods can be applied in many situations. In this
regard, we are now expanding our system of T cell clonal
analysis to determine the nature of a specific target
antigen. As described above, the same clones in different
samples are easily identified by analyzing the PCR pro-
ducts in the same electrophoresis gel. Therefore, we can
compare, for example, in vivo accumulating T cell clones
in a pathologic lesion and T cell clones generated by in
vitro stimulation of PBL with a putative antigen.
In conclusion, antigen-specific T cell clones appear 
to play important roles not only in organ-specific auto-
immune diseases, but also in systemic autoimmune
diseases. T cell clones accumulated in a relatively
advanced disease phase may be qualitatively different
from those found in the early phase. These T cells 
in both phases may be related to the pathogenesis 
in different ways and, thus, further investigations are 
necessary. Moreover, it is obvious that some of these
clones can be used as the candidate targets of future
immunotherapy.
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